The safety and efficacy of fezolinetant is being evaluated in the Phase III trial of over 1,800 women seeking relief from severe vasomotor symptoms associated with menopause (VMS).
List view / Grid view
UNC School of Medicine
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
In the first large pragmatic trial of its kind in the United States, results from a study show that checking finger-stick blood sugars may not help diabetes patients who do not use insulin.